Caption Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3M Buy
481,700
+441,700
+1,104% +$11.4M 0.1% 217
2025
Q4
$795K Sell
40,000
-120,000
-75% -$2.31M 0.01% 1138
2025
Q3
$2.92M Buy
160,000
+70,000
+78% +$1.15M 0.02% 683
2025
Q2
$1.42M Sell
90,000
-225,000
-71% -$2.86M 0.02% 829
2025
Q1
$3.99M Sell
315,000
-259,000
-45% -$4.07M 0.04% 469
2024
Q4
$12.6M Buy
574,000
+140,300
+32% +$2.95M 0.12% 148
2024
Q3
$7.73M Buy
+433,700
New +$6.95M 0.12% 194
2023
Q2
Sell
-60,000
Closed -$1.04M 1142
2023
Q1
$1.04M Sell
60,000
-40,000
-40% -$710K 0.02% 627
2022
Q4
$1.69M Buy
+100,000
New +$1.61M 0.03% 601
2022
Q1
Sell
-623,900
Closed -$8.24M 1515
2021
Q4
$8.24M Buy
623,900
+583,200
+1,433% +$7.34M 0.09% 304
2021
Q3
$322K Sell
40,700
-1,500
-4% -$10.3K ﹤0.01% 1282
2021
Q2
$290K Buy
+42,200
New +$260K ﹤0.01% 1134

Other funds holding CLMT

Caption Management's CLMT Position: Q1 2026 in Review

Caption Management sold out of Calumet Specialty Products (CLMT) in Q1 2026, closing a stake of 5,457 shares — an estimated $141K sold.

Caption Management first reported a position in CLMT in Q1 2021 and held it in 10 quarters. The position peaked at $6.09M in Q3 2021. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Caption Management reported no remaining Calumet Specialty Products position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 5,457 Calumet Specialty Products shares in Q1 2026, an estimated $141K.
  • Caption Management first reported a position in Calumet Specialty Products in Q1 2021 and held it in 10 quarters.
  • Caption Management's Calumet Specialty Products position peaked at $6.09M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.